SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: technetium who wrote (20721)8/1/2006 4:32:16 PM
From: keokalani'nui  Read Replies (2) | Respond to of 52153
 
No guess at all, honestly. Even if I did, the FDA is likely to have its own 'unknowable' opinion regardless what the advisory committee says.

genta has tried so hard and it's in a contest entry, so I'm pulling for but not betting on them.



To: technetium who wrote (20721)8/1/2006 5:32:27 PM
From: former_pgs  Read Replies (1) | Respond to of 52153
 
My bet is that Genta receives an Approvable letter, and will get on the market pending results of the newly initiated trial.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News